...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
AGORACOM NEWS FLASH

ATTENTION MEMBERS: 

Tonight, we're giving our website a serious makeover.  

So if you can't access the site for a bit, don't worry, we're just sprucing things up for an even smoother experience.  

In the event that you experience issues accessing the new site, please clear your browser's cookies and cache. 

See You On The Other Side!

Message: Re: Zenith Epigenetics Receives US$5 Million Milestone Payment from Newsoara
Reply New Message
Back To Forum List View
Icon president Zenith Epigenetics Receives US$5 Million Milestone Payment from Newsoara
3
BearDownAZ
Jan 07, 2020 09:11AM
Re: Zenith Epigenetics Receives US$5 Million Milestone Payment from Newsoara
7
dutchfella
Jan 07, 2020 11:59AM
Re: Zenith Epigenetics Receives US$5 Million Milestone Payment from Newsoara
5
fuzzyjr
Jan 07, 2020 06:28PM
Re: Zenith Epigenetics Receives US$5 Million Milestone Payment from Newsoara
4
Nextblockbuster
Feb 02, 2020 09:48AM

maybe here? Thanks to bear! 

American Association for Cancer Research 2020 meeting in San Diego end of April. https://www.aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=213

 

2 Recommendations
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply